The institutional investor, Stream Value Fund, is to back the founders of Transgene Biotek as the Indian firm seeks to delist itself from the Bombay Stock Exchange.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?